Cephapirin Benzathine
Specifications
97468-37-6CAS Number
bis((6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid);N,N'-dibenzylethane-1,2-diamineIUPAC Name
C50H54N8O12S4Chemical Formula
1087.3 g/molMolecular Weight
Cephapirin benzathine; Cefapirin benzathine; ToMORROW; ToMORROW intramammary infusion; UNII-90G868409O; Cephapirin benzathine (USP); Cephapirin benzathine [USP]; 90G868409O; (6R,7R)-3-(Hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid compound with N,N'-dibenzylethylenediamine (2:1); CEPHAPIRIN COMPD WITH N,N'-DIBENZYLETHYLENEDIAMINE; CEPHAPIRIN BENZATHINE (USP-RS); CEPHAPIRIN BENZATHINE [USP-RS]; CEPHAPIRIN BENZATHINE (USP IMPURITY); CEPHAPIRIN BENZATHINE [USP IMPURITY]; CEPHAPIRIN BENZATHINE (USP MONOGRAPH); CEPHAPIRIN BENZATHINE [USP MONOGRAPH]; Cefa-Dri; RefChem:54750; 97468-37-6; Metricure; (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;N,N'-dibenzylethane-1,2-diamine; Cefapirin (sodium); MFCD09029421; C50H54N8O12S4; Cefapirinbenzathine; Cefa-Dri (TN); SCHEMBL467178; CHEMBL3989837; AKOS032944865; CCG-270637; EBC-145023; FC32163; CEPHAPIRIN BENZATHINE [GREEN BOOK]; DA-72088; HY-113735; CS-0063059; D07637; E77135; Q27271322; CEPHAPIRIN COMPD WITH N,N'-DIBENZYLETHYLENEDIAMINE [MI]; (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(4-pyridylsulfanyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;N,N'-dibenzylethane-1,2-diamine; (6R-trans)-3-[(Acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid compd. with N,N'-Bis(phenylmethyl)-1,2-ethanediamine; N1,N2-Dibenzylethane-1,2-diamine bis((6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(pyridin-4-ylthio)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)Synonyms